Health ❯ Healthcare ❯ Pharmaceuticals

Generic Drugs

Semaglutide Ozempic Diabetes Medications Drug Pricing Drug Shortages Obesity Treatment Weight Loss Medications Lisdexamfetamine Dimesylate Atorvastatin Calcium GLP-1 Therapies

Sun Pharma Wins South African Approval for Generic Semaglutide

The clearance could expand access by allowing once-weekly, lower-cost semaglutide pens for adults with poorly controlled type 2 diabetes.

Pfizer Lung Cancer Drug Fails to Improve Survival in Late‑Stage Trial

Apotex Raises $1.3 Billion in Upsized TSX IPO as Shares Jump on Debut

Generic Semaglutide Hits Canadian Pharmacy Shelves

Canada Expands Access to Semaglutide With Home Delivery and First G7 Generics

Health Canada Approves Apotex’s Generic Ozempic, Opening Canada’s Market to Lower-Cost Semaglutide

Canada Approves First Generic Ozempic, Clearing Dr. Reddy’s Semaglutide

Cipla Wins FDA Approval for First AB-Rated Generic of Ventolin HFA

Telangana Drug Regulator Flags 75 Pharmacies in GLP-1 Sales Crackdown

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

Multiple Indian Drugmakers Win U.S. Clearance to Sell Farxiga Generic

India Tightens Oversight as Low‑Cost Semaglutide Hits Pharmacies

India Rolls Out Low-Cost Semaglutide Generics After Patent Expiry

Semaglutide Patent Expires in Brazil, Opening Door to Lower-Cost Rivals

Brazil's Semaglutide Patent Expires Friday, Opening Door to Ozempic Generics

FDA Class II Recall Targets Generic Vyvanse After Dissolution Failures

FDA Class II Recall Issued for 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

FDA Class II Recall Targets 142,000 Bottles of Ascend’s Atorvastatin

Delhi High Court Rejects Roche Appeal, Clears Natco’s ₹15,900 Generic Risdiplam

UK ‘Postcode Lottery’ for Weight-Loss Jabs Persists as Generics Line Up for 2026